ID   FHOD3_HUMAN             Reviewed;        1422 AA.
AC   Q2V2M9; A8MQT4; E5F5Q0; Q642I2; Q6ZRQ7; Q86TF9; Q8N3A5; Q9C0G8; Q9H604;
AC   Q9H6G7;
DT   17-APR-2007, integrated into UniProtKB/Swiss-Prot.
DT   13-JUL-2010, sequence version 2.
DT   28-JUN-2023, entry version 138.
DE   RecName: Full=FH1/FH2 domain-containing protein 3;
DE   AltName: Full=Formactin-2;
DE   AltName: Full=Formin homolog overexpressed in spleen 2;
DE            Short=hFHOS2;
GN   Name=FHOD3; Synonyms=FHOS2, KIAA1695;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Fetal brain;
RX   PubMed=15966898; DOI=10.1111/j.1365-2443.2005.00867.x;
RA   Kanaya H., Takeya R., Takeuchi K., Watanabe N., Jing N., Sumimoto H.;
RT   "Fhos2, a novel formin-related actin-organizing protein, probably
RT   associates with the nestin intermediate filament.";
RL   Genes Cells 10:665-678(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), FUNCTION, INTERACTION WITH SQSTM1,
RP   SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-1474 AND THR-1476 (ISOFORM 4),
RP   AND TISSUE SPECIFICITY.
RX   PubMed=21149568; DOI=10.1083/jcb.201005060;
RA   Iskratsch T., Lange S., Dwyer J., Kho A.L., dos Remedios C., Ehler E.;
RT   "Formin follows function: a muscle-specific isoform of FHOD3 is regulated
RT   by CK2 phosphorylation and promotes myofibril maintenance.";
RL   J. Cell Biol. 191:1159-1172(2010).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-654 AND 906-1422 (ISOFORM 1).
RC   TISSUE=Small intestine, and Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 203-1422 (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11214970; DOI=10.1093/dnares/7.6.347;
RA   Nagase T., Kikuno R., Hattori A., Kondo Y., Okumura K., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIX. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:347-355(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 895-1422.
RC   TISSUE=Brain, and PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1009-1422.
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [9]
RP   VARIANTS CMH28 VAL-321; ARG-351; CYS-363; ARG-371; HIS-383; GLU-419;
RP   LEU-440; GLY-459; GLY-462; PRO-462; TRP-462; SER-466; SER-469; LYS-479;
RP   LYS-640; CYS-653; THR-657; ASN-770; LEU-865; THR-871; GLN-1194; HIS-1356;
RP   GLY-1376 AND 1397-ARG--LEU-1422 DEL (ISOFORM 1), VARIANTS CMH28 SER-527
RP   DEL; CYS-528 AND GLU-542 (ISOFORM 4), AND INVOLVEMENT IN CMH28.
RX   PubMed=30442288; DOI=10.1016/j.jacc.2018.10.001;
RA   Ochoa J.P., Sabater-Molina M., Garcia-Pinilla J.M., Mogensen J.,
RA   Restrepo-Cordoba A., Palomino-Doza J., Villacorta E., Martinez-Moreno M.,
RA   Ramos-Maqueda J., Zorio E., Pena-Pena M.L., Garcia-Granja P.E.,
RA   Rodriguez-Palomares J.F., Cardenas-Reyes I.J., de la Torre-Carpente M.M.,
RA   Bautista-Paves A., Akhtar M.M., Cicerchia M.N., Bilbao-Quesada R.,
RA   Mogollon-Jimenez M.V., Salazar-Mendiguchia J., Mesa Latorre J.M.,
RA   Arnaez B., Olavarri-Miguel I., Fuentes-Canamero M.E., Lamounier A. Jr.,
RA   Perez Ruiz J.M., Climent-Paya V., Perez-Sanchez I., Trujillo-Quintero J.P.,
RA   Lopes L.R., Reparaz-Andrade A., Marin-Iglesias R., Rodriguez-Vilela A.,
RA   Sandin-Fuentes M., Garrote J.A., Cortel-Fuster A., Lopez-Garrido M.,
RA   Fontalba-Romero A., Ripoll-Vera T., Llano-Rivas I., Fernandez-Fernandez X.,
RA   Isidoro-Garcia M., Garcia-Giustiniani D., Barriales-Villa R.,
RA   Ortiz-Genga M., Garcia-Pavia P., Elliott P.M., Gimeno J.R., Monserrat L.;
RT   "Formin homology 2 domain containing 3 (FHOD3) is a genetic basis for
RT   hypertrophic cardiomyopathy.";
RL   J. Am. Coll. Cardiol. 72:2457-2467(2018).
RN   [10]
RP   VARIANT CMH28 SER-527 DEL (ISOFORM 4), AND INVOLVEMENT IN CMH28.
RX   PubMed=31742804; DOI=10.1002/jgm.3146;
RA   Huang S., Pu T., Wei W., Xu R., Wu Y.;
RT   "Exome sequencing identifies a FHOD3 p.S527del mutation in a Chinese family
RT   with hypertrophic cardiomyopathy.";
RL   J. Gene Med. 22:e3146-e3146(2020).
CC   -!- FUNCTION: Actin-organizing protein that may cause stress fiber
CC       formation together with cell elongation (By similarity). Isoform 4 may
CC       play a role in actin filament polymerization in cardiomyocytes.
CC       {ECO:0000250, ECO:0000269|PubMed:21149568}.
CC   -!- SUBUNIT: Interacts with nestin/NES-based interfilament (IF) (By
CC       similarity). Interacts with SQSTM1; isoform 4 threonine phosphorylation
CC       disrupts SQSTM1-binding. {ECO:0000250, ECO:0000269|PubMed:21149568}.
CC   -!- INTERACTION:
CC       Q2V2M9; Q13501: SQSTM1; NbExp=6; IntAct=EBI-6395541, EBI-307104;
CC       Q2V2M9-4; Q13501: SQSTM1; NbExp=4; IntAct=EBI-6395505, EBI-307104;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000269|PubMed:21149568}. Note=Main part of the protein localizes
CC       to actin fibers and the remaining part displays filamentous staining.
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 4]: Cytoplasm, myofibril, sarcomere, Z
CC       line. Note=Threonine phosphorylation in isoform 4-specific sequence
CC       TDTDEEEEVE is required for targeting to myofibrils in cardiomyocytes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q2V2M9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q2V2M9-2; Sequence=VSP_024397, VSP_024398;
CC       Name=3;
CC         IsoId=Q2V2M9-3; Sequence=VSP_024398;
CC       Name=4;
CC         IsoId=Q2V2M9-4; Sequence=VSP_044682, VSP_024398, VSP_044683;
CC   -!- TISSUE SPECIFICITY: Expressed in the heart, kidney and brain. May be
CC       down-regulated in various types of heart diseases, including idiopathic
CC       dilated, ventricular dilated, familial dilated and perinatal dilated
CC       cardiomyopathies, as well as ischemic heart disease (at protein level).
CC       {ECO:0000269|PubMed:15966898, ECO:0000269|PubMed:21149568}.
CC   -!- DOMAIN: The DAD domain regulates activation via by an autoinhibitory
CC       interaction with the GBD/FH3 domain. This autoinhibition is released
CC       upon competitive binding of an activated GTPase. The release of DAD
CC       allows the FH2 domain to then nucleate and elongate nonbranched actin
CC       filaments (By similarity). {ECO:0000250}.
CC   -!- PTM: [Isoform 4]: Phosphorylated on Thr-1474 and Thr-1476 by CK2.
CC       {ECO:0000269|PubMed:21149568}.
CC   -!- DISEASE: Cardiomyopathy, familial hypertrophic, 28 (CMH28)
CC       [MIM:619402]: A form of hypertrophic cardiomyopathy, a heart disorder
CC       characterized by ventricular hypertrophy, which is usually asymmetric
CC       and often involves the interventricular septum. The symptoms include
CC       dyspnea, syncope, collapse, palpitations, and chest pain. They can be
CC       readily provoked by exercise. The disorder has inter- and intrafamilial
CC       variability ranging from benign to malignant forms with high risk of
CC       cardiac failure and sudden cardiac death. CMH28 is an autosomal
CC       dominant form with incomplete penetrance. {ECO:0000269|PubMed:30442288,
CC       ECO:0000269|PubMed:31742804}. Note=The disease is caused by variants
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the formin homology family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAB15292.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB15463.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB084087; BAC67014.1; -; mRNA.
DR   EMBL; HM191478; ADL62709.1; -; mRNA.
DR   EMBL; AC023043; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC055840; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090333; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131053; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK025950; BAB15292.1; ALT_INIT; mRNA.
DR   EMBL; AK026370; BAB15463.1; ALT_INIT; mRNA.
DR   EMBL; AK128053; BAC87252.1; -; mRNA.
DR   EMBL; AB051482; BAB21786.1; -; mRNA.
DR   EMBL; BC050670; AAH50670.1; -; mRNA.
DR   EMBL; BC081563; AAH81563.1; -; mRNA.
DR   EMBL; AL834480; CAD39139.1; -; mRNA.
DR   CCDS; CCDS32816.1; -. [Q2V2M9-3]
DR   CCDS; CCDS62418.1; -. [Q2V2M9-4]
DR   CCDS; CCDS62419.1; -. [Q2V2M9-1]
DR   RefSeq; NP_001268668.1; NM_001281739.2. [Q2V2M9-1]
DR   RefSeq; NP_001268669.1; NM_001281740.2. [Q2V2M9-4]
DR   RefSeq; NP_079411.2; NM_025135.4. [Q2V2M9-3]
DR   RefSeq; XP_005258412.1; XM_005258355.1. [Q2V2M9-2]
DR   AlphaFoldDB; Q2V2M9; -.
DR   SMR; Q2V2M9; -.
DR   BioGRID; 123175; 7.
DR   ELM; Q2V2M9; -.
DR   IntAct; Q2V2M9; 5.
DR   GlyGen; Q2V2M9; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q2V2M9; -.
DR   PhosphoSitePlus; Q2V2M9; -.
DR   BioMuta; FHOD3; -.
DR   DMDM; 300669639; -.
DR   EPD; Q2V2M9; -.
DR   jPOST; Q2V2M9; -.
DR   MassIVE; Q2V2M9; -.
DR   MaxQB; Q2V2M9; -.
DR   PaxDb; Q2V2M9; -.
DR   PeptideAtlas; Q2V2M9; -.
DR   ProteomicsDB; 61508; -. [Q2V2M9-1]
DR   ProteomicsDB; 61509; -. [Q2V2M9-2]
DR   ProteomicsDB; 61510; -. [Q2V2M9-3]
DR   Antibodypedia; 8734; 67 antibodies from 13 providers.
DR   DNASU; 80206; -.
DR   Ensembl; ENST00000257209.8; ENSP00000257209.3; ENSG00000134775.16. [Q2V2M9-3]
DR   Ensembl; ENST00000359247.8; ENSP00000352186.3; ENSG00000134775.16. [Q2V2M9-1]
DR   Ensembl; ENST00000590592.6; ENSP00000466937.1; ENSG00000134775.16. [Q2V2M9-4]
DR   GeneID; 80206; -.
DR   KEGG; hsa:80206; -.
DR   MANE-Select; ENST00000590592.6; ENSP00000466937.1; NM_001281740.3; NP_001268669.1. [Q2V2M9-4]
DR   UCSC; uc002kzs.3; human. [Q2V2M9-1]
DR   AGR; HGNC:26178; -.
DR   CTD; 80206; -.
DR   DisGeNET; 80206; -.
DR   GeneCards; FHOD3; -.
DR   HGNC; HGNC:26178; FHOD3.
DR   HPA; ENSG00000134775; Tissue enhanced (heart).
DR   MalaCards; FHOD3; -.
DR   MIM; 609691; gene.
DR   MIM; 619402; phenotype.
DR   neXtProt; NX_Q2V2M9; -.
DR   OpenTargets; ENSG00000134775; -.
DR   PharmGKB; PA134929910; -.
DR   VEuPathDB; HostDB:ENSG00000134775; -.
DR   eggNOG; KOG1925; Eukaryota.
DR   GeneTree; ENSGT00940000154807; -.
DR   HOGENOM; CLU_000814_0_1_1; -.
DR   InParanoid; Q2V2M9; -.
DR   OMA; GHYSDGH; -.
DR   OrthoDB; 2918313at2759; -.
DR   PhylomeDB; Q2V2M9; -.
DR   TreeFam; TF316268; -.
DR   PathwayCommons; Q2V2M9; -.
DR   SignaLink; Q2V2M9; -.
DR   SIGNOR; Q2V2M9; -.
DR   BioGRID-ORCS; 80206; 14 hits in 1153 CRISPR screens.
DR   ChiTaRS; FHOD3; human.
DR   GenomeRNAi; 80206; -.
DR   Pharos; Q2V2M9; Tbio.
DR   PRO; PR:Q2V2M9; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q2V2M9; protein.
DR   Bgee; ENSG00000134775; Expressed in apex of heart and 158 other tissues.
DR   ExpressionAtlas; Q2V2M9; baseline and differential.
DR   Genevisible; Q2V2M9; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; IBA:GO_Central.
DR   GO; GO:0030018; C:Z disc; IEA:UniProtKB-SubCell.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0055003; P:cardiac myofibril assembly; IBA:GO_Central.
DR   GO; GO:0030866; P:cortical actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0030837; P:negative regulation of actin filament polymerization; IEA:Ensembl.
DR   GO; GO:0045214; P:sarcomere organization; IBA:GO_Central.
DR   Gene3D; 1.20.58.2220; Formin, FH2 domain; 1.
DR   Gene3D; 1.25.10.10; Leucine-rich Repeat Variant; 1.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR014767; DAD_dom.
DR   InterPro; IPR015425; FH2_Formin.
DR   InterPro; IPR042201; FH2_Formin_sf.
DR   InterPro; IPR041387; FHOD1_GBD_N.
DR   InterPro; IPR014768; GBD/FH3_dom.
DR   PANTHER; PTHR45920:SF3; FH1/FH2 DOMAIN-CONTAINING PROTEIN 3; 1.
DR   PANTHER; PTHR45920; FORMIN HOMOLOGY 2 DOMAIN CONTAINING, ISOFORM I; 1.
DR   Pfam; PF02181; FH2; 1.
DR   Pfam; PF18382; Formin_GBD_N; 1.
DR   SMART; SM00498; FH2; 1.
DR   SUPFAM; SSF48371; ARM repeat; 1.
DR   SUPFAM; SSF101447; Formin homology 2 domain (FH2 domain); 1.
DR   PROSITE; PS51231; DAD; 1.
DR   PROSITE; PS51444; FH2; 1.
DR   PROSITE; PS51232; GBD_FH3; 1.
PE   1: Evidence at protein level;
KW   Actin-binding; Alternative splicing; Cardiomyopathy; Coiled coil;
KW   Cytoplasm; Cytoskeleton; Disease variant; Phosphoprotein;
KW   Reference proteome.
FT   CHAIN           1..1422
FT                   /note="FH1/FH2 domain-containing protein 3"
FT                   /id="PRO_0000283791"
FT   DOMAIN          18..411
FT                   /note="GBD/FH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00579"
FT   DOMAIN          827..858
FT                   /note="FH1"
FT   DOMAIN          883..1279
FT                   /note="FH2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00774"
FT   DOMAIN          1359..1391
FT                   /note="DAD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00577"
FT   REGION          323..464
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          521..666
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          687..708
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          754..781
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          821..850
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1262..1305
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1320..1357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1374..1410
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          448..480
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        323..339
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        368..390
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        398..452
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        526..551
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        589..620
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        621..635
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        636..650
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        687..702
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        825..850
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1281..1298
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1337..1355
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q76LL6"
FT   MOD_RES         375
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q76LL6"
FT   MOD_RES         763
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q76LL6"
FT   MOD_RES         775
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q76LL6"
FT   VAR_SEQ         399
FT                   /note="K -> KEEEEEEEQPITEPSSEEEREDDASCQGKDSKVGAASGQSPTGRDAA
FT                   PKSSALPAVSNASSQGKPLLVGTAGGTTWHSGSSGSEATPSALLSPPASAARPSSATPG
FT                   SLKVSPTIDKLPYVPHSPFHLFSYDFEDSSLSTKEKEAESQKENSSSDSFSLSTYSASE
FT                   PYHFRSFSSNR (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:21149568"
FT                   /id="VSP_044682"
FT   VAR_SEQ         400..437
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11214970"
FT                   /id="VSP_024397"
FT   VAR_SEQ         481
FT                   /note="F -> FSRDYLDKREEQRQAREE (in isoform 2, isoform 3 and
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:11214970,
FT                   ECO:0000303|PubMed:21149568"
FT                   /id="VSP_024398"
FT   VAR_SEQ         1282..1283
FT                   /note="TD -> TDTDEEEEVE (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:21149568"
FT                   /id="VSP_044683"
FT   VARIANT         321
FT                   /note="A -> V (in CMH28; unknown pathological significance;
FT                   dbSNP:rs752857554)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085890"
FT   VARIANT         351
FT                   /note="G -> R (in CMH28; unknown pathological significance;
FT                   dbSNP:rs760471234)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085891"
FT   VARIANT         363
FT                   /note="R -> C (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085892"
FT   VARIANT         371
FT                   /note="K -> R (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085893"
FT   VARIANT         383
FT                   /note="Q -> H (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085894"
FT   VARIANT         419
FT                   /note="V -> E (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085895"
FT   VARIANT         440
FT                   /note="P -> L (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085896"
FT   VARIANT         459
FT                   /note="R -> G (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085897"
FT   VARIANT         462
FT                   /note="R -> G (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085898"
FT   VARIANT         462
FT                   /note="R -> P (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085899"
FT   VARIANT         462
FT                   /note="R -> W (in CMH28; unknown pathological significance;
FT                   dbSNP:rs758818742)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085900"
FT   VARIANT         466
FT                   /note="R -> S (in CMH28; unknown pathological significance;
FT                   dbSNP:rs370344363)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085901"
FT   VARIANT         469
FT                   /note="R -> S (in CMH28; unknown pathological significance;
FT                   dbSNP:rs774149210)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085902"
FT   VARIANT         475
FT                   /note="R -> W (in dbSNP:rs9964535)"
FT                   /id="VAR_055804"
FT   VARIANT         479
FT                   /note="N -> K (in CMH28; unknown pathological significance;
FT                   dbSNP:rs368544178)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085903"
FT   VARIANT         640
FT                   /note="E -> K (in CMH28; unknown pathological significance;
FT                   dbSNP:rs1451852171)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085904"
FT   VARIANT         653
FT                   /note="G -> C (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085905"
FT   VARIANT         657
FT                   /note="A -> T (in CMH28; unknown pathological significance;
FT                   dbSNP:rs757717851)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085906"
FT   VARIANT         770
FT                   /note="D -> N (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085907"
FT   VARIANT         865
FT                   /note="P -> L (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085908"
FT   VARIANT         871
FT                   /note="A -> T (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085909"
FT   VARIANT         1194
FT                   /note="R -> Q (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085910"
FT   VARIANT         1356
FT                   /note="N -> H (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085911"
FT   VARIANT         1376
FT                   /note="V -> G (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085912"
FT   VARIANT         1397..1422
FT                   /note="Missing (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085913"
FT   CONFLICT        71
FT                   /note="D -> G (in Ref. 1; BAC67014)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        202
FT                   /note="K -> E (in Ref. 2; ADL62709)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        432
FT                   /note="E -> G (in Ref. 2; ADL62709)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        435
FT                   /note="L -> W (in Ref. 1; BAC67014)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        527
FT                   /note="S -> G (in Ref. 2; ADL62709)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        581
FT                   /note="G -> A (in Ref. 2; ADL62709)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        647
FT                   /note="S -> P (in Ref. 2; ADL62709)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        654
FT                   /note="L -> K (in Ref. 4; BAC87252)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1134
FT                   /note="V -> I (in Ref. 6; AAH81563)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1417
FT                   /note="T -> A (in Ref. 4; BAB15463)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         Q2V2M9-4:1474
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:21149568"
FT   MOD_RES         Q2V2M9-4:1476
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:21149568"
FT   VARIANT         Q2V2M9-4:527
FT                   /note="Missing (in CMH28)"
FT                   /evidence="ECO:0000269|PubMed:30442288,
FT                   ECO:0000269|PubMed:31742804"
FT                   /id="VAR_085914"
FT   VARIANT         Q2V2M9-4:528
FT                   /note="Y -> C (in CMH28)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085915"
FT   VARIANT         Q2V2M9-4:542
FT                   /note="A -> E (in CMH28; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:30442288"
FT                   /id="VAR_085916"
SQ   SEQUENCE   1422 AA;  158613 MW;  7CE7A8C0054856BE CRC64;
     MATLACRVQF LDDTDPFNST NFPEPSRPPL FTFREDLALG TQLAGVHRLL QAPHKLDDCT
     LQLSHNGAYL DLEATLAEQR DELEGFQDDA GRGKKHSIIL RTQLSVRVHA CIEKLYNSSG
     RDLRRALFSL KQIFQDDKDL VHEFVVAEGL TCLIKVGAEA DQNYQNYILR ALGQIMLYVD
     GMNGVINRNE TIQWLYTLIG SKFRLVVKTA LKLLLVFVEY SESNAPLLIQ AVTAVDTKRG
     VKPWSNIMEI LEEKDGVDTE LLVYAMTLVN KTLSGLPDQD TFYDVVDCLE ELGIAAVSQR
     HLNKKGTDLD LVEQLNIYEV ALRHEDGDET TEPPPSGCRD RRRASVCSSG GGEHRGLDRR
     RSRRHSVQSI KSTLSAPTSP CSQSAPSFKP NQVRDLREKY SNFGNNSYHS SRPSSGSSVP
     TTPTSSVSPP QEARLERSSP SGLLTSSFRQ HQESLAAERE RRRQEREERL QRIEREERNK
     FRYKYLEQLA AEEHEKELRS RSVSRGRADL SLDLTSPAAP ACLAPLSHSP SSSDSQEALT
     VSASSPGTPH HPQASAGDPE PESEAEPEAE AGAGQVADEA GQDIASAHEG AETEVEQALE
     QEPEERASLS EKERQNEGVN ERDNCSASSV SSSSSTLERE EKEDKLSRDR TTGLWPAGVQ
     DAGVNGQCGD ILTNKRFMLD MLYAHNRKSP DDEEKGDGEA GRTQQEAEAV ASLATRISTL
     QANSQTQDES VRRVDVGCLD NRGSVKAFAE KFNSGDLGRG SISPDAEPND KVPETAPVQP
     KTESDYIWDQ LMANPRELRI QDMDFTDLGE EDDIDVLDVD LGHREAPGPP PPPPPTFLGL
     PPPPPPPLLD SIPPPPVPGN LLVPPPPVFN APQGLGWSQV PRGQPTFTKK KKTIRLFWNE
     VRPFDWPCKN NRRCREFLWS KLEPIKVDTS RLEHLFESKS KELSVSKKTA ADGKRQEIIV
     LDSKRSNAIN IGLTVLPPPR TIKIAILNFD EYALNKEGIE KILTMIPTDE EKQKIQEAQL
     ANPEIPLGSA EQFLLTLSSI SELSARLHLW AFKMDYETTE KEVAEPLLDL KEGIDQLENN
     KTLGFILSTL LAIGNFLNGT NAKAFELSYL EKVPEVKDTV HKQSLLHHVC TMVVENFPDS
     SDLYSEIGAI TRSAKVDFDQ LQDNLCQMER RCKASWDHLK AIAKHEMKPV LKQRMSEFLK
     DCAERIIILK IVHRRIINRF HSFLLFMGHP PYAIREVNIN KFCRIISEFA LEYRTTRERV
     LQQKQKRANH RERNKTRGKM ITDSGKFSGS SPAPPSQPQG LSYAEDAAEH ENMKAVLKTS
     SPSVEDATPA LGVRTRSRAS RGSTSSWTMG TDDSPNVTDD AADEIMDRIV KSATQVPSQR
     VVPRERKRSR ANRKSLRRTL KSGLTPEEAR ALGLVGTSEL QL
//
